These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2543019)

  • 1. Appearance of a stereotyped apomorphine-induced climbing in unresponsive DBA2 mice after subchronic manipulations of brain dopamine transmission.
    Duterte-Boucher D; Costentin J
    Psychopharmacology (Berl); 1989; 98(1):56-60. PubMed ID: 2543019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of apomorphine-induced stereotyped behaviour by acute treatment with dopamine depleting agents: a potential role for an increased stimulation of D1 dopamine receptors.
    Vasse M; Protais P
    Neuropharmacology; 1989 Sep; 28(9):931-9. PubMed ID: 2554186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of atrial natriuretic peptide on apomorphine-induced stereotyped cage-climbing behavior in mice.
    Bidzseranova A; Gueron J; Tóth G; Penke B; Telegdy G
    Eur J Pharmacol; 1992 Feb; 211(3):411-4. PubMed ID: 1352255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rapid and prolonged facilitation of stereotyped motor behavior (verticalization) induced by apomorphine in mice previously submitted to stimulation of dopaminergic receptors].
    Costentin J; Marçais H; Protais P; Schwartz JC
    C R Acad Hebd Seances Acad Sci D; 1976 Mar; 282(9):913-6. PubMed ID: 820479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of multiple dopamine receptors in apomorphine and N-n-propylnorapomorphine-induced climbing and hypothermia.
    Moore NA; Axton MS
    Eur J Pharmacol; 1990 Mar; 178(2):195-201. PubMed ID: 2184043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verticalization of behavior elicited by dopaminergic mobilization is qualitatively different between C57BL/6J and DBA/2J mice.
    Tirelli E; Witkin JM
    Psychopharmacology (Berl); 1994 Oct; 116(2):191-200. PubMed ID: 7862948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unexpected potentiation by discriminant benzamide derivatives of stereotyped behaviours elicited by dopamine agonists in mice.
    Vasse M; Protais P; Costentin J; Schwartz JC
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Apr; 329(2):108-16. PubMed ID: 4040215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rat climbing behavior elicited by stimulation of cerebral dopamine receptors.
    Protais P; Bonnet JJ; Costentin J; Schwartz JC
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Feb; 325(2):93-101. PubMed ID: 6425703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible noradrenergic involvement in naloxone potentiation of apomorphine-induced stereotypic climbing in mice.
    Quock RM; Bloom AS; Sadowski JA
    Pharmacol Biochem Behav; 1984 Nov; 21(5):733-6. PubMed ID: 6096896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Climbing and stereotyped behaviours in mice require the stimulation of D-1 dopamine receptors.
    Vasse M; Chagraoui A; Protais P
    Eur J Pharmacol; 1988 Mar; 148(2):221-9. PubMed ID: 2897924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic comparison of apomorphine-induced behavioral changes in two mouse strains with inherited differences in brain dopamine receptors.
    Seale TW; McLanahan K; Johnson P; Carney JM; Rennert OM
    Pharmacol Biochem Behav; 1984 Aug; 21(2):237-44. PubMed ID: 6541342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Climbing behavior induced by apomorphine in mice: a simple test for the study of dopamine receptors in striatum.
    Protais P; Costentin J; Schwartz JC
    Psychopharmacology (Berl); 1976 Oct; 50(1):1-6. PubMed ID: 827755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitization of apomorphine-induced stereotyped behavior in mice is context dependent.
    Battisti JJ; Uretsky NJ; Wallace LJ
    Psychopharmacology (Berl); 1999 Sep; 146(1):42-8. PubMed ID: 10485963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of stereotyped behaviour in Mastomys natalensis.
    Gulati A; Srimal RC; Dhawan BN
    Naunyn Schmiedebergs Arch Pharmacol; 1988 May; 337(5):572-5. PubMed ID: 3412495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticipatory responding, exclusive drug-context pairing and conditioned effects in sensitization to apomorphine-induced climbing in mice.
    Tirelli E; Heidbreder CA
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Apr; 23(3):505-18. PubMed ID: 10378233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D2 dopamine antisense RNA expression vector, unlike haloperidol, produces long-term inhibition of D2 dopamine-mediated behaviors without causing Up-regulation of D2 dopamine receptors.
    Davidkova G; Zhou LW; Morabito M; Zhang SP; Weiss B
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1187-96. PubMed ID: 9618422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological involvement of the calcium channel blocker flunarizine in dopamine transmission at the striatum.
    Belforte JE; Magariños-Azcone C; Armando I; Buño W; Pazo JH
    Parkinsonism Relat Disord; 2001 Sep; 8(1):33-40. PubMed ID: 11472878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A gradual score to evaluate the climbing behaviour elicited by apomorphine in mice.
    Marcais H; Protais P; Costentin J; Schwartz JC
    Psychopharmacology (Berl); 1978 Mar; 56(2):233-4. PubMed ID: 417378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential ability of selective and non-selective dopamine agonists to induce climbing in the rat indicates the involvement of both D-1 and D-2 receptors in this behaviour.
    Davis A; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1990; 100(1):19-26. PubMed ID: 1967499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apomorphine stereotypies and transmitter mechanisms in the striatum. I. Changes in the apomorphine stereotypies caused by drugs acting on the GABA-ergic, dopaminergic and cholinergic transmission.
    Georgiev VP; Markovska VL; Petkova BP
    Acta Physiol Pharmacol Bulg; 1978; 4(3):56-64. PubMed ID: 220843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.